Dimitra Desse
Papers
1
Total Citations
2
H-Index
1
About
Dimitra Desse is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic ablative radiotherapy (SABR) for early-stage lung cancer. Her major contributions center on evaluating non-invasive, high-precision alternatives to surgery for patients who are medically inoperable or who decline surgical intervention. Her most-cited work, a 2024 interim analysis on robotic SABR, demonstrates the safety and efficacy of this technique, offering a compelling therapeutic pathway for vulnerable populations. This study has already garnered attention, accumulating 2 citations shortly after publication and establishing her as a key voice in the shift toward personalized, minimally invasive cancer care. Desse’s research directly addresses a critical gap in oncology: expanding curative treatment options for patients with limited surgical candidacy. Her ongoing work promises to refine dose delivery and patient selection, with the potential to improve outcomes and quality of life for lung cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1